Company / Operating Margin
Edwards Lifesciences Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
20.8%
FY2025
5-year range
20.8% / 33.6%
FY2021-FY2025
Trend
-17.8%
vs FY2024
Sector context
#14 of 148
Health Care
What the data says
Among 148 Health Care companies, Edwards Lifesciences is in the top 9% for operating margin. Operating Margin has declined for 3 consecutive years, from 33.6% in FY2022 to 20.8% in FY2025.
Based on SEC 10-K filings.
20.8% in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Declined from 32.3% to 20.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -12.7pp
- 5-Year Change
- +0.4pp
- 10-Year Change
- -
Sector benchmark
Top 9% in Health CareTop 9% of 148This company 20.8% Sector average -284.8%
▼
+107.3% above sector average
Key checks
Key Insights
- Edwards Lifesciences's operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 17.8% year-over-year.
- Currently 305.6pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 20.8% | -17.8% |
| FY2024 | 25.4% | -21.5% |
| FY2023 | 32.3% | -3.8% |
| FY2022 | 33.6% | +3.9% |
| FY2021 | 32.3% | +57.9% |
| FY2020 | 20.5% | -22.4% |
| FY2019 | 26.4% | +31.2% |
| FY2018 | 20.1% | -36.6% |
| FY2017 | 31.7% | +25.1% |
| FY2016 | 25.4% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026